Sign inJoin waitlistJoin the waitlist

MK

Mary Keohan

Associate Attending Physician · New York Presbyterian Hospital

Credentials: · ·

History

New York Presbyterian Hospital
Present

THE KINGS COLLEGE
1995–1998
Internal Medicine
Cooper Medical School of Rowan University/Cooper University Hospital
1992–1995
University of Medicine and Dentistry of New Jersey
1990–1993
ST GEORGE'S UNIV SCH OF MED, ST GEORGE'S, GRENADA
1986–1990

Research

Phase II study of sorafenib in patients with metastatic or recurrent sarcomas
Journal of Clinical Oncology · 2009 · 450 citations
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a…
Journal of Clinical Oncology · 2009 · 436 citations
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma
Journal of Clinical Oncology · 2013 · 351 citations

MD
Mark Dickson
44 papers
Mrinal Gounder
43 papers
WT
William Tap
43 papers
SD
Sandra D'Angelo
40 papers · 15 as a resident
CA
Cristina Antonescu
36 papers
PC
Ping Chi
35 papers
Samuel Singer
31 papers · 8 as a resident
RM
Robert Maki
29 papers
CK
Ciara Kelly
27 papers
Sujana Movva
25 papers
ER
Evan Rosenbaum
22 papers · 3 as a fellow
Gary Schwartz
18 papers

Clinical trials

Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma
Principal investigator · Completed · Phase 1, Phase 2
National Cancer Institute (NCI)
2011–2013
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2007–2010